Cargando…
Single residue modulators of amyloid formation in the N-terminal P1-region of α-synuclein
Alpha-synuclein (αSyn) is a protein involved in neurodegenerative disorders including Parkinson’s disease. Amyloid formation of αSyn can be modulated by the ‘P1 region’ (residues 36-42). Here, mutational studies of P1 reveal that Y39A and S42A extend the lag-phase of αSyn amyloid formation in vitro...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411612/ https://www.ncbi.nlm.nih.gov/pubmed/36008493 http://dx.doi.org/10.1038/s41467-022-32687-1 |
_version_ | 1784775308443910144 |
---|---|
author | Ulamec, Sabine M. Maya-Martinez, Roberto Byrd, Emily J. Dewison, Katherine M. Xu, Yong Willis, Leon F. Sobott, Frank Heath, George R. van Oosten Hawle, Patricija Buchman, Vladimir L. Radford, Sheena E. Brockwell, David J. |
author_facet | Ulamec, Sabine M. Maya-Martinez, Roberto Byrd, Emily J. Dewison, Katherine M. Xu, Yong Willis, Leon F. Sobott, Frank Heath, George R. van Oosten Hawle, Patricija Buchman, Vladimir L. Radford, Sheena E. Brockwell, David J. |
author_sort | Ulamec, Sabine M. |
collection | PubMed |
description | Alpha-synuclein (αSyn) is a protein involved in neurodegenerative disorders including Parkinson’s disease. Amyloid formation of αSyn can be modulated by the ‘P1 region’ (residues 36-42). Here, mutational studies of P1 reveal that Y39A and S42A extend the lag-phase of αSyn amyloid formation in vitro and rescue amyloid-associated cytotoxicity in C. elegans. Additionally, L38I αSyn forms amyloid fibrils more rapidly than WT, L38A has no effect, but L38M does not form amyloid fibrils in vitro and protects from proteotoxicity. Swapping the sequence of the two residues that differ in the P1 region of the paralogue γSyn to those of αSyn did not enhance fibril formation for γSyn. Peptide binding experiments using NMR showed that P1 synergises with residues in the NAC and C-terminal regions to initiate aggregation. The remarkable specificity of the interactions that control αSyn amyloid formation, identifies this region as a potential target for therapeutics, despite their weak and transient nature. |
format | Online Article Text |
id | pubmed-9411612 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-94116122022-08-27 Single residue modulators of amyloid formation in the N-terminal P1-region of α-synuclein Ulamec, Sabine M. Maya-Martinez, Roberto Byrd, Emily J. Dewison, Katherine M. Xu, Yong Willis, Leon F. Sobott, Frank Heath, George R. van Oosten Hawle, Patricija Buchman, Vladimir L. Radford, Sheena E. Brockwell, David J. Nat Commun Article Alpha-synuclein (αSyn) is a protein involved in neurodegenerative disorders including Parkinson’s disease. Amyloid formation of αSyn can be modulated by the ‘P1 region’ (residues 36-42). Here, mutational studies of P1 reveal that Y39A and S42A extend the lag-phase of αSyn amyloid formation in vitro and rescue amyloid-associated cytotoxicity in C. elegans. Additionally, L38I αSyn forms amyloid fibrils more rapidly than WT, L38A has no effect, but L38M does not form amyloid fibrils in vitro and protects from proteotoxicity. Swapping the sequence of the two residues that differ in the P1 region of the paralogue γSyn to those of αSyn did not enhance fibril formation for γSyn. Peptide binding experiments using NMR showed that P1 synergises with residues in the NAC and C-terminal regions to initiate aggregation. The remarkable specificity of the interactions that control αSyn amyloid formation, identifies this region as a potential target for therapeutics, despite their weak and transient nature. Nature Publishing Group UK 2022-08-25 /pmc/articles/PMC9411612/ /pubmed/36008493 http://dx.doi.org/10.1038/s41467-022-32687-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Ulamec, Sabine M. Maya-Martinez, Roberto Byrd, Emily J. Dewison, Katherine M. Xu, Yong Willis, Leon F. Sobott, Frank Heath, George R. van Oosten Hawle, Patricija Buchman, Vladimir L. Radford, Sheena E. Brockwell, David J. Single residue modulators of amyloid formation in the N-terminal P1-region of α-synuclein |
title | Single residue modulators of amyloid formation in the N-terminal P1-region of α-synuclein |
title_full | Single residue modulators of amyloid formation in the N-terminal P1-region of α-synuclein |
title_fullStr | Single residue modulators of amyloid formation in the N-terminal P1-region of α-synuclein |
title_full_unstemmed | Single residue modulators of amyloid formation in the N-terminal P1-region of α-synuclein |
title_short | Single residue modulators of amyloid formation in the N-terminal P1-region of α-synuclein |
title_sort | single residue modulators of amyloid formation in the n-terminal p1-region of α-synuclein |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411612/ https://www.ncbi.nlm.nih.gov/pubmed/36008493 http://dx.doi.org/10.1038/s41467-022-32687-1 |
work_keys_str_mv | AT ulamecsabinem singleresiduemodulatorsofamyloidformationinthenterminalp1regionofasynuclein AT mayamartinezroberto singleresiduemodulatorsofamyloidformationinthenterminalp1regionofasynuclein AT byrdemilyj singleresiduemodulatorsofamyloidformationinthenterminalp1regionofasynuclein AT dewisonkatherinem singleresiduemodulatorsofamyloidformationinthenterminalp1regionofasynuclein AT xuyong singleresiduemodulatorsofamyloidformationinthenterminalp1regionofasynuclein AT willisleonf singleresiduemodulatorsofamyloidformationinthenterminalp1regionofasynuclein AT sobottfrank singleresiduemodulatorsofamyloidformationinthenterminalp1regionofasynuclein AT heathgeorger singleresiduemodulatorsofamyloidformationinthenterminalp1regionofasynuclein AT vanoostenhawlepatricija singleresiduemodulatorsofamyloidformationinthenterminalp1regionofasynuclein AT buchmanvladimirl singleresiduemodulatorsofamyloidformationinthenterminalp1regionofasynuclein AT radfordsheenae singleresiduemodulatorsofamyloidformationinthenterminalp1regionofasynuclein AT brockwelldavidj singleresiduemodulatorsofamyloidformationinthenterminalp1regionofasynuclein |